Interstitial Pneumonitis after Treatment with Pemetrexed for Non-small Cell Lung Cancer

被引：11
|
作者：
Kim, Kyeong-Hyun [1 ]
Song, Seo-Young [1 ]
Lim, Kyu-Hyoung [1 ]
Han, Seon-Sook [1 ]
Kim, Se-Hyun [1 ]
Cho, Jun Hwi [2 ]
Park, Chan Woo [2 ]
Lee, Seoungkoo [3 ]
Lee, Hui-Young [1 ]
机构：
[1] Kangwon Natl Univ, Sch Med, Kangwon Natl Univ Hosp, Dept Internal Med, Chunchon 200701, South Korea
[2] Kangwon Natl Univ, Sch Med, Kangwon Natl Univ Hosp, Dept Emergency Med, Chunchon 200701, South Korea
[3] Kangwon Natl Univ, Sch Med, Kangwon Natl Univ Hosp, Dept Pathol, Chunchon 200701, South Korea
来源：
CANCER RESEARCH AND TREATMENT | 2013年 / 45卷 / 01期
关键词：
Interstitial lung diseases; Pemetrexed; Non-small-cell lung carcinoma; Adenocarcinoma; Drug therapy; EFFICACY;
D O I：
10.4143/crt.2013.45.1.74
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Pemetrexed is approved as a first-line treatment for advanced non-squamous non-small cell lung cancer (NSCLC) with cisplatin and as a single agent for second-line treatment or for patients who show no disease progression after four cycles of platinum-based doublet induction chemotherapy as maintenance therapy. Pemetrexed has a modest toxicity profile and has not traditionally been regarded as a cause of interstitial pneumonitis. Here, we report on a rare case of pemetrexed-induced pneumonitis in a patient with NSCLC.
引用
收藏
页码：74 / 77
页数：4
相关论文
共 50 条
  • [1] Pemetrexed for the treatment of non-small cell lung cancer
    Genova, Carlo
    Rijavec, Erika
    Truini, Anna
    Coco, Simona
    Sini, Claudio
    Barletta, Giulia
    Dal Bello, Maria Giovanna
    Alama, Angela
    Savarino, Grazia
    Pronzato, Paolo
    Boccardo, Francesco
    Grossi, Francesco
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (11) : 1545 - 1558
  • [2] Pemetrexed in the treatment of non-small cell lung cancer
    Shepherd, FA
    [J]. SEMINARS IN ONCOLOGY, 2002, 29 (06) : 43 - 48
  • [3] Pemetrexed for treatment of advanced non-small cell lung cancer
    Fossella, FV
    [J]. SEMINARS IN ONCOLOGY, 2004, 31 (01) : 100 - 105
  • [4] Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease
    Kato M.
    Shukuya T.
    Takahashi F.
    Mori K.
    Suina K.
    Asao T.
    Kanemaru R.
    Honma Y.
    Muraki K.
    Sugano K.
    Shibayama R.
    Koyama R.
    Shimada N.
    Takahashi K.
    [J]. BMC Cancer, 14 (1)
  • [5] PEMETREXED-INDUCED PNEUMONITIS IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Igata, Fumiyasu
    Ishii, Hiroshi
    Hirano, Ryosuke
    Fujita, Masaki
    Watanabe, Kentaro
    [J]. RESPIROLOGY, 2014, 19 : 151 - 151
  • [6] Intercalation of Erlotinib and Pemetrexed in the Treatment of Non-Small Cell Lung Cancer
    Li, Tianhong
    Lara, Primo N., Jr.
    Mack, Philip C.
    Perez-Soler, Roman
    Gandara, David R.
    [J]. CURRENT DRUG TARGETS, 2010, 11 (01) : 85 - 94
  • [7] Pemetrexed combination therapy in the treatment of non-small cell lung cancer
    Rosell, R
    Crinó, L
    [J]. SEMINARS IN ONCOLOGY, 2002, 29 (02) : 23 - 29
  • [8] Treatment of Non-Small Cell Lung Cancer: Focus on Pemetrexed Disodium
    Feliciano, Josephine
    Patel, Jyoti
    [J]. CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2010, 2 : 737 - 748
  • [9] RETROSPECTIVE ANALYSIS OF PEMETREXED IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER
    Shimada, M.
    Kitazaki, T.
    Fukuda, M.
    Hashiguchi, K.
    Ogawara, D.
    Yamaguchi, H.
    Tomonaga, N.
    Soda, H.
    Nakamura, Y.
    Kohno, S.
    [J]. RESPIROLOGY, 2012, 17 : 80 - 80
  • [10] RETROSPECTIVE ANALYSIS OF PEMETREXED IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER
    Kitazaki, Takeshi
    Ogawara, Daiki
    Yamaguchi, Hiroyuki
    Fukuda, Minoru
    Shimada, Midori
    Ikeda, Takaya
    Tomonaga, Nanae
    Soda, Hiroshi
    Nakamura, Yoichi
    Kohno, Shigeru
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S489 - S489
12345